The power to control one’s health is shifting more each day from life sciences companies and healthcare organisations to the consumers themselves. Never have consumers had so many options for personalised therapies or greater control over their well-being.
With the life sciences industry intensifying its focus on patient outcomes, manufacturers are now putting less effort into treating disease via the mass production of therapies and medical devices and more on meeting patients where they are by providing the best possible care to achieve the best possible outcomes.
Advancements in technology, refinements in regulatory oversight, the proliferation of customisation, and
innovative therapies are shaping new opportunities in pharmaceutical and medical device manufacturing.
The following brief from our strategic partners at MasterControl, examines the major technology, economic, regulatory, and therapeutic trends that will have the biggest impact on life sciences manufacturers this year.
*About MasterControl
MasterControl Inc. is a leading provider of cloud-based quality and manufacturing software for life sciences and other regulated industries. For three decades, our mission has been the same as that of our customers – to bring life-changing products to more people sooner. MasterControl helps organisations digitise, automate, and connect quality and manufacturing processes. Innovative MasterControl tools have a proven track record of improving product quality, reducing cost, and accelerating time to market. Over 1,100 companies worldwide use MasterControl solutions to streamline operations, maintain compliance, easily analyse and interpret large amounts of data, and visualise business insights in real time.
Submit the form below to access the full MasterControl article 2025 Pharma and Medical Device Trends for Manufacturing Leaders.